SAN FRANCISCO, Oct. 15, 2019 /PRNewswire/ -- The global bioburden testing market size is expected to reach USD 2.01 billion by 2026, expanding at a CAGR of 13.7% during the forecast period, according ...
Bioburden Testing Market: Premium Industry Insights. This report aims to provide detailed insights into the global bioburden testing market. It provides valuable information on the type, procedure, ...
As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...
When sterilizing medical devices, sterilization personnel rely on bioburden counts as part of determining and maintaining the sterilization process. In the following Q&A, Martell Winters, senior ...
Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...
Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The Bioburden Testing Market is ...
Growth in the Medical Devices, Pharmaceutical, and Biotechnology Industries. Rising Safety Concerns Related to Food and Beverage Products. Increasing Number of Product Recalls Due to Microbial ...
The quality of water for pharmaceutical production (purified water, water for injection, and ultrapure water) is quantified and regulated through four parameters – total organic carbon (TOC), ...
The Global Bioburden Testing Market has experienced consistent growth, with a compound annual growth rate (CAGR) of 12-15%. This growth is driven by tightening regulatory standards and an increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback